Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.

Abstract

Therefore, the targeting of urokinase to the GP IIb/IIIa platelet receptor both accelerates clot lysis (when platelets are associated with a fibrin clot) and inhibits platelet aggregation.